BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30036273)

  • 1. Integrin and PD-1 Ligand Expression on Circulating Extracellular Vesicles in Systemic Inflammatory Response Syndrome and Sepsis.
    Kawamoto E; Masui-Ito A; Eguchi A; Soe ZY; Prajuabjinda O; Darkwah S; Park EJ; Imai H; Shimaoka M
    Shock; 2019 Jul; 52(1):13-22. PubMed ID: 30036273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte integrin expression differences between SIRS and sepsis patients.
    Heffernan DS; Monaghan SF; Ayala A
    Ir J Med Sci; 2017 Nov; 186(4):981-987. PubMed ID: 27796667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activity.
    Hirahara S; Katsumata Y; Kawasumi H; Kawaguchi Y; Harigai M
    Lupus; 2020 Jun; 29(7):686-696. PubMed ID: 32264742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study.
    Wilson JK; Zhao Y; Singer M; Spencer J; Shankar-Hari M
    Crit Care; 2018 Apr; 22(1):95. PubMed ID: 29661225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia.
    Jalali S; Price-Troska T; Paludo J; Villasboas J; Kim HJ; Yang ZZ; Novak AJ; Ansell SM
    Blood Adv; 2018 Aug; 2(15):1985-1997. PubMed ID: 30104397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.
    Ricklefs FL; Alayo Q; Krenzlin H; Mahmoud AB; Speranza MC; Nakashima H; Hayes JL; Lee K; Balaj L; Passaro C; Rooj AK; Krasemann S; Carter BS; Chen CC; Steed T; Treiber J; Rodig S; Yang K; Nakano I; Lee H; Weissleder R; Breakefield XO; Godlewski J; Westphal M; Lamszus K; Freeman GJ; Bronisz A; Lawler SE; Chiocca EA
    Sci Adv; 2018 Mar; 4(3):eaar2766. PubMed ID: 29532035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamine Administration in Early or Late Septic Phase Downregulates Lymphocyte PD-1/PD-L1 Expression and the Inflammatory Response in Mice With Polymicrobial Sepsis.
    Hu YM; Hsiung YC; Pai MH; Yeh SL
    JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):538-549. PubMed ID: 28633555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel role for programmed cell death receptor ligand 2 in sepsis-induced hepatic dysfunction.
    Rossi AL; Le M; Chung CS; Chen Y; Fallon EA; Matoso A; Xu S; Chun TT; Erickson CP; Ayala A
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G106-G114. PubMed ID: 30431333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1.
    Patera AC; Drewry AM; Chang K; Beiter ER; Osborne D; Hotchkiss RS
    J Leukoc Biol; 2016 Dec; 100(6):1239-1254. PubMed ID: 27671246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte programmed death ligand-1 expression after 3-4 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study.
    Shao R; Fang Y; Yu H; Zhao L; Jiang Z; Li CS
    Crit Care; 2016 May; 20(1):124. PubMed ID: 27156867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sepsis is characterized by the increases in percentages of circulating CD4+CD25+ regulatory T cells and plasma levels of soluble CD25.
    Saito K; Wagatsuma T; Toyama H; Ejima Y; Hoshi K; Shibusawa M; Kato M; Kurosawa S
    Tohoku J Exp Med; 2008 Sep; 216(1):61-8. PubMed ID: 18719339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The concentration of programmed cell death-ligand 1 in the peripheral blood is a useful biomarker for esophageal squamous cell carcinoma.
    Akutsu Y; Murakami K; Kano M; Toyozumi T; Matsumoto Y; Takahashi M; Otsuka R; Sekino N; Yokoyama M; Shiraishi T; Matsubara H
    Esophagus; 2018 Apr; 15(2):103-108. PubMed ID: 29892935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Value of Soluble Programmed Death-1 for Severe Sepsis and Septic Shock During the First Week in an Intensive Care Unit.
    Zhao Y; Jia Y; Li C; Shao R; Fang Y
    Shock; 2019 Mar; 51(3):289-297. PubMed ID: 29702526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells.
    Jiao Q; Liu C; Li W; Li W; Fang F; Qian Q; Zhang X
    Clin Exp Immunol; 2017 Jun; 188(3):420-429. PubMed ID: 28052400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-soluble PD-L1 may be a potential diagnostic biomarker in sepsis.
    Sun S; Chen Y; Liu Z; Tian R; Liu J; Chen E; Mao E; Pan T; Qu H
    Scand J Immunol; 2021 Jul; 94(1):e13049. PubMed ID: 33934376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin expression on neutrophils in a rabbit model of Group B Streptococcal meningitis.
    Rowin ME; Xue V; Irazuzta J
    Inflammation; 2000 Apr; 24(2):157-73. PubMed ID: 10718117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of cytokine-mediated beta2-integrin activation on circulating neutrophils in critically ill patients.
    Rosenbloom AJ; Pinsky MR; Napolitano C; Nguyen TS; Levann D; Pencosky N; Dorrance A; Ray BK; Whiteside T
    J Leukoc Biol; 1999 Jul; 66(1):83-9. PubMed ID: 10410993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation.
    Li W; Tu J; Liu X; Yang W
    Clin Exp Immunol; 2017 Oct; 190(1):8-18. PubMed ID: 28556912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapse.
    Hoffmann O; Wormland S; Bittner AK; Collenburg M; Horn PA; Kimmig R; Kasimir-Bauer S; Rebmann V
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1159-1174. PubMed ID: 35366112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte Programmed Death Ligand-1, A Predicator for 28-Day Mortality in Septic Patients.
    Tai H; Xing H; Xiang D; Zhu Z; Mei H; Sun W; Zhang W
    Am J Med Sci; 2018 Apr; 355(4):362-367. PubMed ID: 29661350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.